Research peptide drugs (e.g., CJC 1295, Ipamorelin, BPC 157) are the newest trend in the fitness space, although they've been popular in the wellness space for quite some time. Despite their popularity, the The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Research Inland Psychiatric Medical Group Under reporting of harm in clinical trials The Lancet Oncology